Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin added to interferon-beta in relapsing-remitting multiple sclerosis
2005-001009-25Phase 2Completed
- Sponsor
- DR DIMENSIONE RICERCA
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atorvastatin in multiple sclerosis (MS) (2 arms), sponsored by DR DIMENSIONE RICERCA. Primary endpoint: Change in brain atrophy after 24 months. Started Mar 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-001009-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001009-25.